Loading clinical trials...
Loading clinical trials...
A Comparison of Telmisartan 80 mg + Hydrochlorothiazide 12.5 mg With Amlodipine 10 mg + Hydrochlorothiazide 12.5 mg in the Control of Blood Pressure in Older Patients With Predominantly Systolic Hypertension. A Prospective, Randomised, Open-label, Blinded End-point Evaluation. (ATHOS Study)
Conditions
Interventions
Telmisartan 80 mg + hydrochlorothiazide 12.5 mg
Amlodipine 10 mg + hydrochlorothiazide 12.5 mg
Locations
73
Belgium
A.C.Z. Antwerpen/Stuyvenberg
Antwerp, Belgium
Boehringer Ingelheim Investigational Site
Aywaille, Belgium
A.Z. VUB
Brussels, Belgium
C.H.U. Liège (Ourthe-Amblève)
Esneux, Belgium
Boehringer Ingelheim Investigational Site
Aabenraa, Denmark
Boehringer Ingelheim Investigational Site
Christiansfeld, Denmark
Start Date
December 1, 2002
Primary Completion Date
March 1, 2004
Completion Date
March 1, 2004
Last Updated
November 1, 2013
NCT02417740
NCT07480265
NCT07073820
NCT06876233
NCT06062394
NCT06899815
Lead Sponsor
Boehringer Ingelheim
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions